JD Health International Inc. (HKG:6618)

JD Health International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22,629	15,037	18,718	17,252	32,271
Short-Term Investments	15,126	16,799	27,951	23,637	6,525
Trading Asset Securities	10,438	9,385	1,003	1,101	1,508
Cash & Short-Term Investments	48,193	41,221	47,672	41,990	40,303
Cash Growth	16.91%	-13.53%	13.53%	4.18%	533.65%
Accounts Receivable	551.37	706.76	1,301	405.68	460.86
Other Receivables	-	265.35	686.59	53.75	46.39
Receivables	551.37	972.1	1,988	459.43	507.25
Inventory	5,843	5,085	5,996	3,041	1,732
Prepaid Expenses	-	16.35	15.79	14.03	6.67
Restricted Cash	32.66	15.38	33	25.35	38.6
Other Current Assets	3,841	540.23	742.43	175.35	116.45
Total Current Assets	58,460	47,850	56,447	45,705	42,705
Property, Plant & Equipment	795.99	288	251.91	260.78	115.01
Long-Term Investments	1,428	13,197	1,523	1,031	714.14
Other Intangible Assets	2,095	2,182	2,268	25.39	28.5
Long-Term Deferred Tax Assets	312.93	299.83	208.47	95.86	21.69
Other Long-Term Assets	8,184	471.77	578.98	883.8	410.44
Total Assets	71,275	64,288	61,277	48,002	43,995
Accounts Payable	10,423	11,340	11,143	5,710	2,900
Accrued Expenses	4,243	305.78	1,204	180.82	171.57
Current Portion of Leases	109.67	95.32	70.65	67.55	28.57
Current Income Taxes Payable	207.1	337.54	380.19	118.81	132.18
Current Unearned Revenue	537.92	405.6	1,375	395.41	179.46
Other Current Liabilities	-	2,100	2,184	1,532	1,270
Total Current Liabilities	15,521	14,585	16,356	8,005	4,682
Long-Term Leases	148.72	119.43	128.76	133.72	61.41
Long-Term Deferred Tax Liabilities	364.41	213.61	7.82	8.89	-
Total Liabilities	16,034	14,918	16,493	8,148	4,743
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	58,551	57,063	56,242	55,633
Retained Earnings	-13,224	-17,336	-19,382	-19,715	-18,603
Treasury Stock	-60.73	-92.57	-34.3	-50.64	-
Comprehensive Income & Other	68,516	8,233	7,134	3,377	2,221
Total Common Equity	55,231	49,356	44,780	39,853	39,251
Minority Interest	9.68	14.51	4.31	1.19	0.5
Shareholders' Equity	55,241	49,370	44,785	39,855	39,251
Total Liabilities & Equity	71,275	64,288	61,277	48,002	43,995
Total Debt	258.39	214.75	199.41	201.27	89.98
Net Cash (Debt)	47,934	41,007	47,473	41,789	40,213
Net Cash Growth	16.89%	-13.62%	13.60%	3.92%	-
Net Cash Per Share	15.17	12.96	15.10	13.50	18.21
Filing Date Shares Outstanding	3,146	3,127	3,106	3,098	3,184
Total Common Shares Outstanding	3,146	3,127	3,106	3,098	3,184
Working Capital	42,939	33,265	40,091	37,700	38,023
Book Value Per Share	17.56	15.78	14.42	12.86	12.33
Tangible Book Value	53,137	47,174	42,512	39,828	39,222
Tangible Book Value Per Share	16.89	15.08	13.69	12.86	12.32

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.